Blatant lie in less than 6 months? 'launching generic Epidiolex in the U.S. this year'
Dave, why didn't you bother submitting to Health Canada for generic Epidiolex also? Where is your Health Canada drug master file as well?
He F up on his Q1 2024 profitability forecast and has been F up on his 'stock price is undervalued' as well.
After leaving Purdue Pharma Canada (oxycotin head honcho) he ended up at this micro cap stock because no one wanted to touch him...oxycotin radioactive Dave.
Instead of getting revenue contracts he buys VIVO trying to get to a bottom line profit and that didn't work out very well either.
What a F up.